Related Experiment Video
Updated: Jun 9, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course
Eleni Georgoulopoulou1, Cinzia Gellera, Cinzia Bragato
1Department of Neurology, Nuovo Ospedale Civile S. Agostino Estense, Via Giardini 1355, 41126 Modena, Italy.
Abstract:
Approximately 10% of amyotrophic lateral sclerosis (ALS) cases are familial, and the Cu/Zn superoxide dismutase (SOD1) gene mutation accounts for 20% of them. More than 100 SOD1 mutations have been described, some with peculiar phenotypes. Moreover, mutations in the SOD1 gene have been described in apparently sporadic ALS cases. We report a new mutation (D11Y) in the Cu/Zn superoxide dismutase gene in a patient with ALS and an unusually slow disease progression.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Parkinson's Disease: Overview
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

